Jacek Wisniewski, PhD

Max-Planck-Institute of Biochemistry (Germany)

Pierre-Olivier Schmit, PhD

Bruker

Jiri Adamec, PhD

Stanley S. Scott Cancer Center, Department of Interdisciplinary Oncology, New Orleans (USA)

Daniel Martins-de-Souza, PhD

University of Campinas – Unicamp, Campinas (Brazil)

Employing neuroproteomics to decipher the molecular underpinnings of Schizophrenia

Ellen D. McPhail, PhD

Department of Laboratory Medicine and Pathology Tissue Proteomics Clinical Laboratory Mayo Clinic, Rochester (USA)

Proteomics-based classification of membranous nephropathy

Nataly Kravchenko-Balasha, PhD

The Institute of Biomedical and Oral Research, The Hebrew University of Jerusalem, Jerusalem (Israel)

Jean Pieters, PhD

Biozentrum, University of Basel, Basel (Switzerland)

Hugo M. Santos, PhD

NOVA University of Lisbon (Portugal)

Ute Distler, PhD

Core Facility for Mass Spectrometry, Institute for Immunology, University Medical Center Mainz, Mainz (Germany)

Namrata Udeshi, PhD

Broad Institute of MIT and Harvard, Cambridge (USA)

Cell surface and proximity labeling proteomics

Angel Porgador, PhD

Ben-Gurion University of the Negev, Beer-Sheva (Israel)

Alan J. Stewart, PhD

School of Medicine, University of St. Andrews, St.Andrews (Scotland)

Use of quantitative proteomics to understand thrombotic risk in metabolic disease

Taicia Fill, PhD

Chemistry Institute UNICAMP, São Paulo (Brazil)

The Chemistry involved in Pathogen-Host interactions in citrus

Roopali Roy, PhD

Department of Surgery, Harvard Medical School and Boston Children’s Hospital, Boston (USA)

Mining the Urinary Proteome: Identification and Validation of Non-invasive Biomarkers for the Early Detection of Cancer

Jun Wang, PhD

Stony Brook University, The State University of New York, New York (USA)

Single-Cell MIST: An Open Platform for Single-Cell Proteomics and Spatial Biology

Yuichi J. Shimada, PhD

Columbia University Medical Center, New York (USA)

Deciphering the Black Box between Genotype and Phenotype of Hypertrophic Cardiomyopathy through Proteomics Profiling

Luigi Puglielli, PhD

University of Wisconsin-Madison, Wisconsin (USA)

Acetyl-CoA and proteostasis

Ranadhir Chakraborty, PhD

Department of Biotechnology, University of North Bengal, Bengal (India)

Do Bacteria Plan? Molecular Coordination and Anticipatory Logic in Microbial Life

Bruno Manadas, PhD

CNC – Center for Neuroscience and Cell Biology – University of Coimbra, Coimbra (Portugal)

Proteomics Approaches on Hypoxic-ischemic encephalopathy – new biomarkers and mesenchymal stem cell therapy

Noa Martin-Cofreces, PhD

Instituto Investigación Sanitaria Princesa (IIS-Princesa), Madrid (Spain)

Differential proteome and post-translational modifications changes at the centrosome during T lymphocyte activation

Cristina Banfi, PhD

Centro Cardiologico Monzino IRCCS, Unit of Functional Proteomics, Metabolomics, and Network Analysis, Milan (Italy)

ADVANCED QUANTITATIVE PROTEOMICS IDENTIFIES A NOVEL MULTIFUNCTIONAL REGULATOR LINKING ADIPOGENESIS, THROMBOSIS, AND ATHEROSCLEROSIS

Sonia Sharma, PhD

Tenured Associate Professor, La Jolla Institute for Immunology, La Jolla, California (USA)

Bio-active lipid metabolites regulate cancer immunotherapy outcomes and inflammation

Marco Aurélio Zezzi Arruda, PhD

Institute of Chemistry Substitute Executive Director – Funcamp University of Campinas – Unicamp (Brazil)

Michele Mishto, PhD

King’s College London (SE1 1UL) The Francis Crick Institute (NW1), London (UK)

Production, antigenicity and immunogeneicity of proteasome-generated spliced peptides

Ieronymos Zoidakis, PhD

Biomedical Research Foundation, Academy of Athens, Athens (Greece)

Bladder cancer biomarker ruin in urine

Shay Sharon, PhD

Hadassah and Hebrew University Medical Center, Jerusalem (Israel)